AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-28.4%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$59M
AUM Growth
+$59M
(-40%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
American Well
AMWL
$109M
| $26.5M | 44.93% |
6,300,773
| – | – |
|
|
RNTX
2
Rein Therapeutics, Inc. Common Stock
RNTX
$31.1M
| $8.51M | 14.42% |
16,609,449
| – | – |
|
|
WHWK
3
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
| $6.36M | 10.77% |
374,785
| – | – |
|
4
Annexon
ANNX
$227M
| $5.34M | 9.04% |
1,954,978
| – | – |
|
5
Assembly Biosciences
ASMB
$185M
| $4.59M | 7.77% |
2,227,500
| – | – |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.37M | 7.41% |
126,270
| – | – |
|
7
Akebia Therapeutics
AKBA
$825M
| $3.34M | 5.66% |
4,652,561
| – | – |
|